Archives

Johnson Controls Announces Second Quarter 2026 Earnings Conference Call Webcast and “Going to Gemba Day” for Investors and Sell-Side Analysts

B CORK, Ireland, April 21, 2026 /PRNewswire/ — Johnson Controls International plc (NYSE: JCI), a global technology leader in energy efficiency, decarbonization, thermal management and mission-critical performance, today announced details…

Read MoreJohnson Controls Announces Second Quarter 2026 Earnings Conference Call Webcast and “Going to Gemba Day” for Investors and Sell-Side Analysts

Jazz Pharmaceuticals to Present Data at ASCO 2026 Highlighting Advancements for Ziihera® (zanidatamab-hrii) in Gastroesophageal Adenocarcinoma and Zepzelca® (lurbinectedin)

P Rapid oral presentation of PD-L1 subgroup data from HERIZON-GEA-01 evaluating zanidatamab combinations, and additional analyses of tolerability, biomarker response and real-world treatment patterns in HER2+ GEA For U.S. media…

Read MoreJazz Pharmaceuticals to Present Data at ASCO 2026 Highlighting Advancements for Ziihera® (zanidatamab-hrii) in Gastroesophageal Adenocarcinoma and Zepzelca® (lurbinectedin)